New perspective on the pathophysiology of panic: Merging serotonin and opioids in the periaqueductal gray

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 4, 2012, Pages 366-375

  Graeff, F G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Animal model; Opioids; Panic; Periaqueductal gray; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; ALLYLGLYCINE; ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIPANIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBON DIOXIDE; CORTICOTROPIN; FLUOXETINE; IMIPRAMINE; LORAZEPAM; MORPHINE; NALOXONE; NEUROTRANSMITTER; OXYMORPHONE; POTASSIUM CYANIDE; PROTEIN C FOS; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; TETRAGASTRIN;

ABDOMINAL DISCOMFORT; AGORAPHOBIA; ANXIETY; ASPHYXIA; BEHAVIOR CHANGE; CEREBROSPINAL FLUID; CHILL; COGNITION; COGNITIVE THERAPY; DEFENSIVE BEHAVIOR; DISTRESS SYNDROME; DRUG MEGADOSE; DYSPNEA; ELECTROSTIMULATION; ESCAPE BEHAVIOR; FEAR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENETIC RISK; GLUCOSE UTILIZATION; HEART PALPITATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW DRUG DOSE; MAZE TEST; MEDULLA OBLONGATA; MESENCEPHALON; NAUSEA; NEUROIMAGING; NONHUMAN; ORGANIC PSYCHOSYNDROME; PANIC; PARKINSONISM; PERIAQUEDUCTAL GRAY MATTER; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWEATING; THALAMUS VENTRAL NUCLEUS; THORAX PAIN; TREMOR; VENTROMEDIAL PREFRONTAL CORTEX; VOXEL BASED MORPHOMETRY;

ANIMALIA; RATTUS;

EID: 84859619778     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500036     Document Type: Review

References (52)

1. Klein DF, Fink M. Psychiatric reaction patterns to imipramine. Am J Psychiatry 1962; 119: 432-438.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn. Washington: American Psychiatric Press; 2000.
3. Del-Ben CM, Graeff FG. Panic disorder: is the PAG involved? Neural Plast 2009; 2009: 108-135.
4. Protopopescu X, Pan H, Tuescher O, Cloitre M, Goldstein M, Engelien A, et al. Increased brainstem volume in panic disorder: a voxel-based morphometric study. Neuroreport 2006; 17:361-363.
5. Uchida RR, Del-Ben CM, Busatto GF, Duran FL, Guimaraes FS, Crippa JA, et al. Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Res 2008; 163:21-29.
6. Fujiwara A, Yoshida T, Otsuka T, Hayano F, Asami T, Narita H, et al. Midbrain volume increase in patients with panic disorder. Psychiatry Clin Neurosci 2011; 65: 365-373.
7. Reiman EM, Raichle ME, Robins E, Mintun MA, Fusselman MJ, Fox PT, et al. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 1989; 46: 493-500.
8. Javanmard M, Shlik J, Kennedy SH, Vaccarino FJ, Houle S, Bradwejn J. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol Psychiatry 1999; 45: 872-882.
9. Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, et al. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage 2006; 33: 218-226.
10. Mobbs D, Petrovic P, Marchant JL, Hassabis D, Weiskopf N, Seymour B, et al. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 2007; 317: 1079-1083.
11. Mobbs D, Marchant JL, Hassabis D, Seymour B, Tan G, Gray M, et al. From threat to fear: the neural organization of defensive fear systems in humans. J Neurosci 2009; 29: 12236-12243.
12. McNaughton N, Corr PJ. A two-dimensional neuropsychol-ogy of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev 2004; 28: 285-305.
13. Graeff FG. Neurotransmitters in the dorsal periaqueductal gray and animal models of panic anxiety. In: Briley M, File SE (Editors), New concepts in anxiety. London: MacMillan Press; 1991. p 288-312.
14. Deakin JF, Graeff FG. 5-HT and mechanisms of defence. J Psychopharmacol 1991; 5: 305-315.
15. Graeff FG, Zangrossi H Jr. The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Cent Nerv Syst Agents Med Chem 2010; 10: 207-217.
16. Graeff FG. On serotonin and experimental anxiety. Psycho-pharmacology 2002; 163: 467-476.
17. Graeff FG, Del-Ben CM. Neurobiology of panic disorder: from animal models to brain neuroimaging. Neurosci Biobe-hav Rev 2008; 32: 1326-1335.
18. Graeff FG. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 2004; 28: 239-259.
19. Blanchard DC, Blanchard RJ. Ethoexperimental approaches to the biology of emotion. Annu Rev Psychol 1988; 39: 43-68.
20. Johnson P, Lowry C, Truitt W, Shekhar A. Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic. J Psychopharmacol 2008; 22: 642-652.
21. Johnson PL, Lightman SL, Lowry CA. A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann N YAcad Sei 2004; 1018: 58-64.
22. Graeff FG, Parente A, Del-Ben CM, Guimaraes FS. Pharmacology of human experimental anxiety. Braz J Med Biol Res 2003; 36: 421-432.
23. Graeff FG, Zuardi AW, Giglio JS, Lima Filho EC, Karniol IG. Effect of metergoline on human anxiety. Psychopharmaco-logy 1985; 86: 334-338.
24. Del-Ben CM, Vilela JA, Hetem LA, Guimaraes FS, Graeff FG, Zuardi AW. Do panic patients process unconditioned fear vs. conditioned anxiety differently than normal subjects? Psychiatry Res 2001; 104: 227-237.
25. Perkins AM, Ettinger U, Davis R, Foster R, Wlliams SC, Corr PJ. Effects of lorazepam andcitalopram on human defensive reactions: ethopharmacological differentiation of fear and anxiety. J Neurosci 2009; 29: 12617-12624.
26. Perkins AM, Ettinger U, Wlliams SC, Reuter M, Hennig J, Corr PJ. Flight behaviour in humans is intensified by a candidate genetic risk factor for panic disorder: evidence from a translational model of fear and anxiety. Mol Psychiatry 2011; 16:242-244.
27. Griebel G, Blanchard DC, Agnes RS, Blanchard RJ. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology 1995; 120:57-66.
28. Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J. Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res 2004; 132: 173-181.
29. Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 2004; 24: 589-591.
30. Prefer M, Klein DF. Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuropsycho-pharmacol Biol Psychiatry 2008; 32: 603-612.
31. Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry-1993; 50: 306-317.
32. Bourin M, Baker GB, Bradwejn J. Neurobiology of panic disorder. J Psychosom Res 1998; 44: 163-180.
33. Graeff FG, Garcia-Leal C, Del-Ben CM, Guimaraes FS. Does the panic attack activate the hypothalamic-pituitary-adrenal axis? An Acad Bras Cienc 2005; 77: 477-491.
34. Garcia-Leal C, Parente AC, Del-Ben CM, Guimaraes FS, Moreira AC, Elias LL, et al. Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking. Psychiatry Res 2005; 133: 239-252.
35. Garcia-Leal C, Del-Ben CM, Leal FM, Graeff FG, Guimaraes FS. Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation. J Psychopharmacol 2010; 24: 683-694.
36. Schenberg LC, Dos Reis AM, Ferreira Povoa RM, Tufik S, Silva SR. A panic attack-like unusual stress reaction. Horm Behav 2008; 54: 584-591.
37. Lim LW, Blokland A, van Duinen M, Visser-Vandewalle V, Tan S, Vlamings R, et al. Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats. Behav Brain Res 2011; 218: 301-307.
38. Graeff FG, Zangrossi H Jr. The hypothalamic-pituitary-adrenal axis in anxiety and panic. Psychol Neurosci 2010; 3: 3-8.
39. Schimitel FG, de Almeida GM, Pitol DN, Armini RS, Tufik S, Schenberg LC. Evidence of a suffocation alarm system within the periaqueductal gray matter of the rat. Neurosci-ence 2012; 200: 59-73.
40. Klein RG. Is panic disorder associated with childhood separation anxiety disorder. Clin Neuropsychopharmacol 1995; 18(Suppl2):7-14.
41. Santos JWQ, Müller CT, Bernabé CS, Rosa CA, Men-donça VA, Schenberg LC. Mother deprivation facilitates and learned helplessness inhibits the defensive behaviors produced by electrical stimulation of the dorsal periaqueductal gray matter (DPAG) of adult rats. XXVI Annual Meeting of Brazilian Federation of Societies of Experimental Biology. Rio de Janeiro: FESBE; 2011. Abstract 23.214.
42. Panksepp J, Nelson E, Bekkedal M. Brain systems for the mediation of social separation-distress and social-reward. Evolutionary antecedents and neuropeptide intermediaries. Ann N YAcad Sei 1997; 807: 78-100.
43. Panksepp J, Herman B, Conner R, Bishop P, Scott JP. The biology of social attachments: opiates alleviate separation distress. Biol Psychiatry 1978; 13: 607-618.
44. Kalin NH, Shelton SE, Barksdale CM. Opiate modulation of separation-induced distress in non-human primates. Brain Res 1988; 440: 285-292.
45. Sinha SS, Goetz RR, Klein DF. Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder. Psychiatry Res 2007; 149:309-314.
46. Prefer M, Lee SH, Petkova E, Vannucci M, Kim S, Klein DF. Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss. Psychol Med 2011; 41: 385-393.
47. Roncon CM, Biesdorf C, Santana RG, Zangrossi H Jr, Graeff FG, Audi EA. The panicolytic-like effect of fluoxetine in the elevated T maze is mediated by serotonin-induced activation of endogenous opioids in the periaqueductal gray. J Psychopharmacol 2012; Jan 24 [Epub ahead of print].
48. Zanoveli JM, Pobbe RL, de Bortoli V, Carvalho MC, Brandão ML, Zangrossi H Jr. Facilitation of 5-HT1A-mediated neu-rotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine. Int J Neuropsychopharmacol 2010; 13: 1079-1088.
49. Xuan YT, Shi YS, Zhou ZF, Han JS. Studies on the me-solimbic loop of antinociception-ll. A serotonin-enkephalin interaction in the nucleus accumbens. Neuroscience 1986; 19:403-409.
50. Osaki MY, Castellan-Baldan L, Calvo F, Carvalho AD, Felippotti TT, de Oliveira R, et al. Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus. Brain Res 2003; 992: 179-192.
51. Hokfelt T. Looking at neurotransmitters in the microscope. Prog Neurobiol 2010; 90: 101-118.
52. Dyakonova V, Carlberg M, Sakharov D, Elofsson R. Anatomical basis for interactions of enkephalins with other transmitters in the CNS of a snail. J Comp Neurol 1995; 361: 38-47.